Categories Earnings, Health Care
UnitedHealth Group beats Q4 earnings estimates; revenues match expectations
UnitedHealth Group (NYSE: UNH) reported better-than-expected earnings for the fourth quarter of 2019 while revenues matched estimates. Shares were down 0.40% in premarket hours on Wednesday.
Total revenues of $61 billion was up 5% from the same period last year and in line with forecasts.

Net earnings attributable to UnitedHealth Group common shareholders was $3.5 billion, or $3.58 per share, compared to $3 billion, or $3.10 per share, last year. Adjusted EPS grew 19% to $3.90, beating estimates of $3.28.
Favorable medical reserve development was $270 million in the quarter, with $150 million related to 2019 and $120 million related to previous years. Year-end days claims payable were 50.8 days compared to 49.5 in the fourth quarter of 2018. Medical costs increased 8% in the period.
During the quarter, revenues in the UnitedHealthcare segment increased 4% to $48.2 billion versus the prior-year period. Revenues in the Optum segment increased 7% year-over-year to $29.8 billion.
Revenues from premiums increased 6%. Revenues from products decreased slightly during the quarter while services revenues increased. Revenues from investment and other income rose 26%.
For the full year of 2020, GAAP EPS is expected to be $15.45 to $15.75 and adjusted EPS is expected to be $16.25 to $16.55.
Get access to timely and accurate verbatim transcripts that are published within hours of the event.
Most Popular
Important takeaways from Conagra Brands’ Q3 2025 report
Conagra Brands, Inc. (NYSE: CAG) has reported weaker-than-expected revenue and profit for the February quarter, with sales declining across all business segments amid softer demand and persistent supply challenges. The
Main takeaways from Lamb Weston’s (LW) Q3 2025 earnings report
Shares of Lamb Weston Holdings, Inc. (NYSE: LW) jumped 9% on Thursday after the company delivered better-than-expected results for the third quarter of 2025 and reaffirmed its outlook for the
Summary: Tesla (TSLA) reports Q1 2025 production, deliveries
Tesla Inc. (NASDAQ: TSLA) has announced results of vehicle production and deliveries for the first quarter of 2025. The company also provided data on the deployment of energy storage products